World's Best Scientists 2026 revealed!
Edward T. Olejniczak

Edward T. Olejniczak

D-Index & Metrics

Chemistry

D-Index
66
Citations
15569
World Ranking
7274
National Ranking
2156

Edward T. Olejniczak publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Edward T. Olejniczak sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 163 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Edward T. Olejniczak D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Edward T. Olejniczak sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 66 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Edward T. Olejniczak is affiliated with Vanderbilt University in the United States. Their research primarily focuses on fields within Biochemistry, Genetics, and Molecular Biology, with specific attention to molecular biology, organic chemistry, oncology, materials chemistry, and hematology.

Olejniczak's work covers main topics such as:

  • Ubiquitin and proteasome pathways
  • Protein degradation and inhibitors
  • Click chemistry and applications
  • Cell death mechanisms and regulation
  • Peptidase inhibition and analysis
  • Cancer-related gene regulation
  • Genomics and chromatin dynamics

Their recent publications include:

  • "Discovery of WD Repeat-Containing Protein 5 (WDR5)-MYC Inhibitors Using Fragment-Based Methods and Structure-Based Design," 2020, Journal of Medicinal Chemistry
  • "Impact of WIN site inhibitor on the WDR5 interactome," 2021, Cell Reports
  • "Discovery of Sulfonamide-Derived Agonists of SOS1-Mediated Nucleotide Exchange on RAS Using Fragment-Based Methods," 2020, Journal of Medicinal Chemistry
  • "Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors," 2024, Journal of Medicinal Chemistry
  • "Structural Elucidation of Peptide Binding to KLHL-12, a Substrate Specific Adapter Protein in a Cul3-Ring E3 Ligase Complex," 2020, Biochemistry

Frequent coauthors collaborating with Olejniczak include:

  • Stephen W. Fesik
  • Bin Zhao
  • William G. Payne
  • Allison L. Arnold
  • John Sensintaffar

Their publications commonly appear in these venues:

  • Journal of Medicinal Chemistry
  • Cell Reports
  • Biochemistry
  • The Cambridge Structural Database
  • RSC Chemical Biology

Edward T. Olejniczak's body of work contributes to understanding molecular mechanisms underlying protein interactions, signaling, and regulation related to various biochemical pathways, including those implicated in cancer and hematological conditions.

Best Publications

  • Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain

    Zhihong Liu;Chaohong Sun;Edward T. Olejniczak;Robert P. Meadows

  • Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation.

    Qi Sun;Jason P. Burke;Jason Phan;Michael C. Burns

  • Rationale for Bcl-XL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies

    Andrew M. Petros;David G. Nettesheim;Yi Wang;Edward T. Olejniczak

  • NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain.

    Baohua Huang;Matthias Eberstadt;Edward T. Olejniczak;Robert P. Meadows

  • Novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 2. Mechanism of inhibition and structure-based improvement of pharmaceutical properties.

    Gang Liu;Jeffrey R. Huth;Edward T. Olejniczak;Renaldo Mendoza

  • Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.

    Thorsten K Oost;Chaohong Sun;Robert C Armstrong;Ali-Samer Al-Assaad

  • Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR

    P. J. Hajduk;G. Sheppard;D. G. Nettesheim;E. T. Olejniczak

  • Structure and ligand recognition of the phosphotyrosine binding domain of Shc.

    Ming-Ming Zhou;Kodimangalam S. Ravichandran;Edward T. Olejniczak;Andrew M. Petros

  • Structural Characterization of a Soluble Amyloid β-Peptide Oligomer

    Liping Yu;Rohinton Edalji;John E. Harlan;Thomas F. Holzman

  • Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYC

    L.R. Thomas;Q. Wang;B.C. Grieb;J. Phan

  • Analysis of deuterium nuclear magnetic resonance line shapes in anisotropic media

    R. J. Wittebort;E. T. Olejniczak;R. G. Griffin

  • A general method for assigning NMR spectra of denatured proteins using 3D HC(CO)NH-TOCSY triple resonance experiments.

    Timothy M. Logan;Edward T. Olejniczak;Robert X. Xu;Stephen W. Fesik

  • Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design

    Anders Friberg;Dominico Vigil;Bin Zhao;R. Nathan Daniels

  • Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein.

    Qiulong Huang;Liping Yu;Andrew M Petros;Angelo Gunasekera

  • Solution structure of a pleckstrin-homology domain.

    Ho Sup Yoon;Philip J. Hajduk;Andrew M. Petros;Edward T. Olejniczak

  • ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens.

    Jeffrey R Huth;Renaldo Mendoza;Edward T Olejniczak;Robert W Johnson

  • NMR Studies of [U-13C]Cyclosporin a Bound to Cyclophilin: Bound Conformation and Portions of Cyclosporin Involved in Binding.

    Fesik Sw;Gampe Rt;Eaton Hl;Gemmecker G

  • NMR Structure and Mutagenesis of the N-Terminal Dbl Homology Domain of the Nucleotide Exchange Factor Trio

    Xiaohong Liu;Hong Wang;Matthias Eberstadt;Arndt Schnuchel

  • Aminopyridine-Based c-Jun N-Terminal Kinase Inhibitors with Cellular Activity and Minimal Cross-Kinase Activity†

    Bruce G Szczepankiewicz;Christi Kosogof;Lissa T J Nelson;Gang Liu

  • 2D and 3D NMR spectroscopy employing carbon-13/carbon-13 magnetization transfer by isotropic mixing. Spin system identification in large proteins

    Stephen W. Fesik;Hugh L. Eaton;Edward T. Olejniczak;Erik R. P. Zuiderweg

  • Solution structure of the cyclosporin A/cyclophilin complex by NMR

    Yves Thériault;Timothy M. Logan;Robert Meadows;Liping Yu

Frequent Co-Authors

Stephen W. Fesik
Stephen W. Fesik Vanderbilt University
Philip J. Hajduk
Philip J. Hajduk National Institutes of Health
Walter J. Chazin
Walter J. Chazin Vanderbilt University
Daniel P. Raleigh
Daniel P. Raleigh Stony Brook University
Shimon Vega
Shimon Vega Weizmann Institute of Science
Shaun R. Stauffer
Shaun R. Stauffer Cleveland Clinic
Ming-Ming Zhou
Ming-Ming Zhou Icahn School of Medicine at Mount Sinai
Donald E. Staunton
Donald E. Staunton CisThera (United States)
Craig B. Thompson
Craig B. Thompson Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in extending their Chemistry studies toward specialized fields, online options such as an online forensic science degree offer a practical pathway. These programs allow students to apply chemical principles to criminal investigations, blending science with law enforcement.

Graduate students might explore forensic psychology graduate programs online, which combine psychology with forensic analysis. This interdisciplinary approach expands traditional Chemistry roles, preparing graduates for varied career opportunities in criminal justice and behavioral assessment.

When considering career outcomes, a forensic science degree salary is an important factor. Salaries can vary widely depending on specialization, location, and experience—highlighting the value of strategic educational choices aligned with career goals.

Prospective students should also assess the financial commitment, referencing details on how much does it cost to get a criminal justice degree. Understanding tuition and fees upfront ensures informed decisions, especially when planning to integrate Chemistry with criminal justice sectors.

Best Scientists Citing Edward T. Olejniczak

Trending Scientists

Recently Published Articles